1668 related articles for article (PubMed ID: 27713627)
21. The association of elevated circulating endocan levels with lung function decline in COPD patients.
Dai L; He J; Chen J; Wang T; Liu L; Shen Y; Chen L; Wen F
Int J Chron Obstruct Pulmon Dis; 2018; 13():3699-3706. PubMed ID: 30519013
[TBL] [Abstract][Full Text] [Related]
22. The objective evaluation of obstructive pulmonary diseases with spirometry.
Ozkaya S; Dirican A; Tuna T
Int J Chron Obstruct Pulmon Dis; 2016; 11():2009-15. PubMed ID: 27616884
[TBL] [Abstract][Full Text] [Related]
23. [Concentrations of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases-1 in serum of patients with chronic obstructive pulmonary disease].
Piesiak P; Brzecka A; Kosacka M; Passowicz-Muszyńska E; Dyła T; Jankowska R
Pol Merkur Lekarski; 2011 Nov; 31(185):270-3. PubMed ID: 22299526
[TBL] [Abstract][Full Text] [Related]
24. Cut-off value of FEV1/FEV6 as a surrogate for FEV1/FVC for detecting airway obstruction in a Korean population.
Chung KS; Jung JY; Park MS; Kim YS; Kim SK; Chang J; Song JH
Int J Chron Obstruct Pulmon Dis; 2016; 11():1957-63. PubMed ID: 27578970
[TBL] [Abstract][Full Text] [Related]
25. Increased matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio in smokers with airway hyperresponsiveness and accelerated lung function decline.
Lo CY; Huang HY; He JR; Huang TT; Heh CC; Sheng TF; Chung KF; Kuo HP; Wang CH
Int J Chron Obstruct Pulmon Dis; 2018; 13():1135-1144. PubMed ID: 29692608
[TBL] [Abstract][Full Text] [Related]
26. Positive correlation of airway resistance and serum asymmetric dimethylarginine level in COPD patients with systemic markers of low-grade inflammation.
Tajti G; Gesztelyi R; Pak K; Papp C; Keki S; Szilasi ME; Mikaczo A; Fodor A; Szilasi M; Zsuga J
Int J Chron Obstruct Pulmon Dis; 2017; 12():873-884. PubMed ID: 28352168
[TBL] [Abstract][Full Text] [Related]
27. Serum IL-1β and IL-17 levels in patients with COPD: associations with clinical parameters.
Zou Y; Chen X; Liu J; Zhou DB; Kuang X; Xiao J; Yu Q; Lu X; Li W; Xie B; Chen Q
Int J Chron Obstruct Pulmon Dis; 2017; 12():1247-1254. PubMed ID: 28490868
[TBL] [Abstract][Full Text] [Related]
28. [Relationships between the expressions of intercellular adhesion molecule-1 and tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 in lung tissues of patients with chronic obstructive pulmonary disease].
Kong YJ; Sun WX; Zhang YM; Shi YZ
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Feb; 31(2):129-33. PubMed ID: 18683786
[TBL] [Abstract][Full Text] [Related]
29. The role of serum soluble urokinase-type plasminogen activator receptor in stable chronic obstructive pulmonary disease.
Can Ü; Güzelant A; Yerlikaya FH; Yosunkaya Ş
J Investig Med; 2014 Oct; 62(7):938-43. PubMed ID: 25127435
[TBL] [Abstract][Full Text] [Related]
30. Circulating matrix metalloproteinase-9 and osteoporosis in patients with chronic obstructive pulmonary disease.
Bolton CE; Stone MD; Edwards PH; Duckers JM; Evans WD; Shale DJ
Chron Respir Dis; 2009; 6(2):81-7. PubMed ID: 19411568
[TBL] [Abstract][Full Text] [Related]
31. Patients with chronic obstructive pulmonary disease and chronically colonized with Haemophilus influenzae during stable disease phase have increased airway inflammation.
Tufvesson E; Bjermer L; Ekberg M
Int J Chron Obstruct Pulmon Dis; 2015; 10():881-9. PubMed ID: 26005341
[TBL] [Abstract][Full Text] [Related]
32. Relationship between serum cardiac troponin T level and cardiopulmonary function in stable chronic obstructive pulmonary disease.
Hattori K; Ishii T; Motegi T; Kusunoki Y; Gemma A; Kida K
Int J Chron Obstruct Pulmon Dis; 2015; 10():309-20. PubMed ID: 25709425
[TBL] [Abstract][Full Text] [Related]
33. Plasminogen activator inhibitor-1, fibrinogen, and lung function in adolescents with asthma and obesity.
Huang F; del-Río-Navarro BE; Alcántara ST; Ontiveros JA; Cienfuegos DR; Bello González SA; Villafaña S; Bravo G; Hong E
Endocr Res; 2012; 37(3):135-44. PubMed ID: 22578058
[TBL] [Abstract][Full Text] [Related]
34. Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease.
Higashimoto Y; Iwata T; Okada M; Satoh H; Fukuda K; Tohda Y
Respir Med; 2009 Aug; 103(8):1231-8. PubMed ID: 19249197
[TBL] [Abstract][Full Text] [Related]
35. Elevated plasma levels of pigment epithelium-derived factor correlated with inflammation and lung function in COPD patients.
Li X; Wang T; Yang T; Shen Y; An J; Liu L; Dong J; Guo L; Li D; Zhang X; Chen L; Xu D; Wen F
Int J Chron Obstruct Pulmon Dis; 2015; 10():587-94. PubMed ID: 25844034
[TBL] [Abstract][Full Text] [Related]
36. COPD assessment test score and serum C-reactive protein levels in stable COPD patients.
Kang HK; Kim K; Lee H; Jeong BH; Koh WJ; Park HY
Int J Chron Obstruct Pulmon Dis; 2016; 11():3137-3143. PubMed ID: 27994452
[TBL] [Abstract][Full Text] [Related]
37. Detection of COPD in a high-risk population: should the diagnostic work-up include bronchodilator reversibility testing?
Kjeldgaard P; Dahl R; Løkke A; Ulrik CS
Int J Chron Obstruct Pulmon Dis; 2015; 10():407-14. PubMed ID: 25759573
[TBL] [Abstract][Full Text] [Related]
38. Inflammatory mediators in exhaled breath condensate and peripheral blood of healthy donors and stable COPD patients.
Hao W; Li M; Zhang C; Zhang Y; Wang P
Immunopharmacol Immunotoxicol; 2019 Apr; 41(2):224-230. PubMed ID: 31046512
[No Abstract] [Full Text] [Related]
39. Risk factors for FEV
Chen S; Wang C; Li B; Shi G; Li H; Zhang J; Gu Y; Zhou J; Song Y; Bai C
Int J Chron Obstruct Pulmon Dis; 2017; 12():435-442. PubMed ID: 28184155
[TBL] [Abstract][Full Text] [Related]
40. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
